James Treace - Jul 18, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor, as Attorney-in-fact for James T. Treace
Stock symbol
TMCI
Transactions as of
Jul 18, 2022
Transactions value $
-$550,671
Form type
4
Date filed
7/20/2022, 07:18 PM
Previous filing
Jul 15, 2022
Next filing
Aug 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale -$208K -13K -1.02% $16.06 1.26M Jul 18, 2022 Direct F1, F2
transaction TMCI Common Stock Sale -$16.2K -983 -0.08% $16.46 1.26M Jul 18, 2022 Direct F1, F3
transaction TMCI Common Stock Sale -$326K -20.2K -1.61% $16.11 1.24M Jul 19, 2022 Direct F1, F4
holding TMCI Common Stock 556K Jul 18, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.38 to $16.37 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.39 to $16.51 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.62 to $16.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.